Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
19.99
+1.09 (5.80%)
At close: Aug 13, 2025, 4:00 PM
20.10
+0.12 (0.58%)
Pre-market: Aug 14, 2025, 7:47 AM EDT
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $1.18 billion as of August 14, 2025. Its market cap has decreased by -5.26% in one year.
Market Cap
1.18B
Enterprise Value
693.13M
1-Year Change
-5.26%
Ranking
Category
Stock Price
$19.99
Market Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $1.18B, an increase of 21.52%. That is a compound annual growth rate of 8.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 1.18B | 7.24% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| Novartis AG | 234.72B |
| AstraZeneca | 232.33B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |